Session Details

[2AS-11]【E】Transdisciplinary research for social implementation of the Gut Design study

Thu. Dec 4, 2025 9:00 AM - 11:00 AM JST
Thu. Dec 4, 2025 12:00 AM - 2:00 AM UTC
Room 11(Pacifico Yokohama Conference Center 4F, 414+415)
Organizer: Nobuo Sasaki (Gunma University), Shinji Fukuda (Keio University)
Development of technologies to control gut microbiota (The Gut Design) is expected because disturbances in the intestinal environment cause the onset of various diseases. Interdisciplinary research is necessary to manipulate gut microbiota, constituting a higher-order complex system. In this symposium, we will discuss the future of Gut Design by presenting state-of-the-art researchers in diverse fields such as gut microbiology and bacteriophage-based therapy, as well as systems biology and metabolism.

Introduction

[2AS-11-01(2P-885)]Analysis of the Impact of Anticancer Drugs on the Gut Microbiota across Multiple Cancer Types: A Case Study of EGFR Inhibitors

○Kyoko Kurihara1,2, Shunsuke A Sakai1,2, Naoko Iida3, Kentaro Sawada4, Satoshi Horasawa3, Takao Fujisawa3,5, Yoshiaki Nakamura3,6, Shun-ichiro Kageyama1, Katsuya Tsuchihara1,2, Riu Yamashita1,7 (1. TI, NCC EPOC, 2. IB, Tokyo Univ., 3. TR, NCCHE, 4. Kushiro Rosai Hospital, 5. HNMO, NCCHE, 6. GO, NCCHE, 7. CBMS, Tokyo Univ.)
Comment()

[2AS-11-02]The Future of Personalized Healthcare: Microbiome-Based Precision Medicine

○natsuki suganuma1 (1. bacterico inc./KEIO Univ.)
Comment()

[2AS-11-03]Enrichment of Horizontally Transferred Gene Clusters in Bacterial Extracellular Vesicles in Human Microbiota

○Sotaro Takano1,2, Akihiro Okamoto2 (1. RIKEN BRC, 2. Research Center for Macromolecules and Biomaterials, NIMS)
Comment()

[2AS-11-04]Advanced Technologies for Deciphering and Modulating Spatiotemporal Gut Microbiome Dynamics

○Lena Takayasu1,2, Rina Kurokawa2, Ioannis Nteka1, Rie Maskawa3, Hiroaki Masuoka2, Hideki Takayasu3, Iwijn DeVlaminck1, Misako Takayasu3, Wataru Suda2 (1. Cornell University, 2. RIKEN, 3. Institute of Science Tokyo)
Comment()

[2AS-11-05]Next-generation phage therapy against intestinal pathobionts

○Kosuke Fujimoto1,2,3 (1. RIMD, Osaka Univ., 2. IMSUT, UTokyo, 3. Osaka Metropolitan Univ.)
Comment()

[2AS-11-06]Cultivation Renaissance in gut bacteria and phage research in the post-metagenomic era: toward gut ecosystem design

○Hideyuki Tamaki1,2 (1. AIST, 2. Univ. Tsukuba)
Comment()

General Discussion

Conclusion